Liệu pháp thay thế hormone cho những người sống sót sau ung thư vú và nội mạc tử cung

Early Breast Cancer Trialists’ Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992, 339:1–15, 71–85. Carpenter JS, Andrykowski MA: Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 1999, 26:1311–1317. Meyerowitz BE, Desmond KA, Rowland JH, et al.: Sexuality following breast cancer. J Sex Marital Ther 1999, 24:237–250. Stein KD, Jacobsen PB, Hahn DM, et al.: Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 2000, 19:436–445. Ganz PA, Coscarelli A, Fred C, et al.: Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 1996, 38:183–199. Schover LR, Yetman RJ, Tuason LJ, et al.: Partial mastectomy and breast reconstruction: a comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 1995, 75:54–64. Ganz PA, Rowland JH, Desmond K, et al.: Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 1998, 16:501–514. Young-McCaughan S: Sexual functioning in women with breast cancer after treatment with adjuvant therapy. Cancer Nursing 1996, 19:308–319. Carpenter JS, Andrykowski MA, Cordova M, et al.: Hot flashes in postmenopausal women treated for breast carcinoma. Cancer 1998, 82:1682–1691. Couzi RJ, Helzlsouer KJ, Fetting JH: Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995, 13:2737–2744. Wile AG, DiSaia PJ: Hormones and breast cancer. Am J Surg 1989, 157:438–442. Holleb AI, Farrow JH: The relation of carcinoma of the breast and pregnancy in 283 patients. Surg Gynecol Obstet 1962, 115:65. Nugent P, O’Connell TX: Breast cancer and pregnancy. Arch Surg 1985, 120:1221–1224. von Schoultz E, Johansson H, Wilking N, Rutqvist LE: Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995, 13:43001–50434. Anderson BO, Petrek JA, Byrd DR, et al.: Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 1996, 3:204–211. Descriptive study of the outcome of young women with breast cancer and the outcome of pregnancy-associated breast cancers. Clark RM, Chua T: Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1989, 1:11–18. Schonborn I, Nischan P, Ebeling K: Oral contraceptive use and the prognosis of breast cancer. Breast Cancer Res Treat 1994, 30:283–292. Sauerbrei W, Blettner M, Schmoor C, et al.: The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group. Eur J Cancer 1998, 34:1348–1351. Bergkvist L, Adami H-O, Persson I, et al.: Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 1989, 130:221–228. DiSaia PJ: Estrogen replacement therapy for the breast cancer survivor: a reappraisal [guest editorial]. J Surg Oncol 1997, 64:175–180. Henderson BE, Paganini-Hill A, Ross RK: Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1996, 151:75–78. Grodstein F, Stampfer MJ, Colditz GA, et al.: Postmenopausal hormone therapy and mortality. N Engl J Med 1997, 336:1769–1775. DiSaia PJ, Odicino F, Grosen EA, et al.: Hormone replacement therapy in breast cancer [letter]. Lancet 1993, 342:1232. DiSaia PJ, Grosen EA, Kurosaki T, et al.: Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 1996, 174:1494–1498. DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H: Breast cancer survival and hormone replacement therapy: a cohort analysis. Am J Clin Oncol 2000, 23:541–545. A matched case-control survival analysis of breast cancer survivors comparing ERT users with nonusers. Eden JA, Bush T, Nand S, Wren BG: A case control study of combined continuous estrogen progestin replacement therapy among women with a personal history of breast cancer. Menopause 1995, 2:67–72. Bluming AZ, Waisman JR, Dosik GM: Hormone replacement therapy (HRT) in women with previously treated primary breast cancer: update III [abstract]. Proc ASCO 1997, 16A:463. Vassilopoulou-Sellin R, Rherriault R, Klein MY: Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer. Gynecol Oncol 1997, 65:89–93. Marsden J, Whitehead M, Hern RA, et al.: Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible? Fertil Steril 2000, 73:292–299. O’Meara ES, Rossing MA, Daling JR, et al.: Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 2001, 93:754–762. A matched case-control analysis of ERT and non-ERT breast cancer survivors. Creasman W, Henderson D, Hinshaw W, Clarke-Pearson D: Estrogen replacement in the patient treated for endometrial cancer. Obstet Gynecol 1986, 67:326–330. Lee R, Burke T, Park R: Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 1990, 36:189–191. Chapman J, DiSaia PJ, Osann K, et al.: Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996, 175:1195–1200. Suriano KA, McHale M, McLaren CE, et al.: Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol 2001, 97:555–560. Matched case-control study of endometrial cancer patients to assess risk of recurrence associated with HRT. Stoll BA: Hormone replacement therapy in women treated for breast cancer. Eur J Cancer Clin Oncol 1989, 25:1909–1913. Wile AG, Opfell RW, Margileth DA: Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 1993, 165:372–375. Powles TJ, Hickish T, Casey S, O’Brien M: Hormone replacement after breast cancer. Lancet 1993, 42:60–61.